A lot of the work to be done, and there is no guarantee of success, but after careful different approaches to developing of a meningitis B vaccine studied believes VaxGen, production method, the a new and promising technology, and we look forward to working with VaxGen to determine if we to the next level to the next level of development. .. B meningitis is a life-threatening bacterial infections, most often in young children. The disease is almost always fatal if left untreated and 10-15 percent fatal, even if treated with antibiotics. Of those who recover the permanent of the disease, 10-20 percent experience hearing loss, mental retardation or loss of limbs. There is no licensed vaccine, has been shown to protect against a broad spectrum of meningitis B strains. – A safe and effective Meningitis B vaccine provide provide a major advance in improving the health of our children, said Lance K.
EndoBiologics ‘ production method, the Dictyostelium discoideum used as a biological mechanism for generating a potential difference vaccine antigen of lipooligosaccharide . LOS a carbohydrate structure on the surface of meningitis B bacteria. Dictyostelium uses meningitis B bacteria as a food source and produces enzymes that detoxify naturally bacterial LOS molecule. The detoxified LOS is protein using conjugated or coupled to a carrier protein using create EndoBiologics ‘ proprietary chemistry to the vaccine candidates.Others risk behavior of the 2007 survey also found that Hispanic high higher drug use than other students. / Contra Costa Times.
During of the 21 – year study, researcher followed over 450 those aged of 75 , beginning in 1980. Neither party suffer with dementia at the beginning of. The investigator follow how much the subscriber develop Alzheimer’s disease and glanced other types of dementia, and the activities it had committed. The seniors who are was mentally active showed the least lessening of mental sharpness.